FDA’s Linda Katz Addresses Why VCRP Wouldn’t Work For Cosmetics Registration Under MoCRA
Executive Summary
The cosmetics office director assured attendees of a 27 April FDLI webinar that the agency’s launch of a new platform for cosmetics registration and product listing will afford companies sufficient time to comply with new requirements under the Modernization of Cosmetic Regulations Act.
You may also be interested in...
CIR Expert Panel: Hyaluronates Safe As Used; Split Conclusion For Olive Ingredients; More
The US-based Expert Panel for Cosmetic Ingredient Safety issued three final and six tentative safety assessments and three insufficient data announcements at its 12-13 June meeting in Washington.
FDA Will Be Motivated To Bring Enforcement Action Under MoCRA; ‘Get Your Ducks In a Row’
The US Food and Drug Administration will have new cosmetics requirements to enforce under the Modernization of Cosmetic Regulations Act, as well as new funds and pressure “to make a show of this,” Locke Lord attorneys said in the law firm’s 31 May “MoCRA and You” webinar.
US FDA Seeks Input On Cosmetics GMP Development, Industry Costs, Likely Safety Impacts
The agency is accepting comments from 27 April to 3 July 2023 to Docket No. FDA-2023-N-1466 to inform its development of good manufacturing practices for facilities that manufacture or process cosmetic products distributed in the United States. A virtual “listening session” is slated for 1 June.